More tools:Markets·Screener·Research·Chat

Microbot Medical, Inc. Common Stock (MBOT) Financial Statements

Microbot Medical, Inc. Common Stock
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG001SD3692
XNAS · usd
1.50▲ 0.06 (4.17%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales—
EV / Revenue—
EV / EBITDA
Financial Highlights
Revenue (TTM)—
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin—
Net Debt
Trading Information
Previous Close1.44
Day's Range1.45 – 1.52
52-Week Range1.44 – 4.67
Volume558.4K
Avg Volume690.9K
Share Statistics
Shares Outstanding
Employees22
ExchangeXNAS
Listed1992-03-25
Share count as of August 11, 2026
Loading Income Statement…
Key questions about Microbot Medical, Inc. Common Stock (MBOT)
What is Microbot Medical, Inc. Common Stock's Market Cap?
Microbot Medical, Inc. Common Stock's Market Cap is $100.7M, based on as-reported figures from SEC (XBRL) filings.
What is Microbot Medical, Inc. Common Stock's Enterprise Value?
Microbot Medical, Inc. Common Stock's Enterprise Value is $33.4M, based on as-reported figures from SEC (XBRL) filings.
What is Microbot Medical, Inc. Common Stock's EV / EBITDA?
Microbot Medical, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Microbot Medical, Inc. Common Stock's Net Income (TTM)?
Microbot Medical, Inc. Common Stock's Net Income (TTM) is -$16.3M, based on as-reported figures from SEC (XBRL) filings.
What is Microbot Medical, Inc. Common Stock's EBITDA?
Microbot Medical, Inc. Common Stock's EBITDA is -$18.5M, based on as-reported figures from SEC (XBRL) filings.
What is Microbot Medical, Inc. Common Stock's Diluted EPS (TTM)?
Microbot Medical, Inc. Common Stock's Diluted EPS (TTM) is -0.24, based on as-reported figures from SEC (XBRL) filings.
What is Microbot Medical, Inc. Common Stock's Net Debt?
Microbot Medical, Inc. Common Stock's Net Debt is -$67.4M, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue——
Cost of Revenues——
Gross loss——
% of revenue-266.8%1.9%——
Research and development, net
Sales, general and administrative
Operating loss
% of revenue-2567.6%-4114.3%——
Non-Operating Income (Expense)——
Interest Expense
Net loss
% of revenue-2334.9%-3496.2%——
Earnings Per Share (Basic)
Earnings Per Share (Diluted)